Drug Research
Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic...
Vesselon, an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent®. Vesselon will use Imagent to create novel therapeutic complexes in four classes...
News
Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement...
Zenith Capital Corp. announced that Zenith Epigenetics Ltd. , a wholly-owned subsidiary of Zenith Capital, has entered into a licensing agreement with Newsoara BioPharma Co.,...
News
Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution...
Aucta Pharmaceuticals, Inc. ,a technology based company focusing on the development and commercialization of Branded Specialty Products, announced that the Company has entered into an...
News
Sempre health partners with Blue cross blue shield of...
Sempre Health, the leading solution for behavior-based healthcare pricing, announced a partnership with Blue Cross Blue Shield of Arizona (BCBSAZ) that features a new way...
Drug Research
FDA Approves Daiichi Sankyos TURALIO pexidartinib for the Treatment...
Daiichi Sankyo Company, Limited announced that the U.S. FDA approved TURALIOâ„¢ (pexidartinib) as the first and only treatment for adult patients with symptomatic TGCT associated...
News
Amicus Therapeutics Receives Marketing Authorization for Galafold for Fabry...
Amicus Therapeutics announced that the Agency of Medicines, Food and Medical Devices (ANMAT) in Argentina has granted approval for the first-in-class, oral small molecule pharmacological...
Clinical Trials
Amicus Announces Positive Interim Clinical Data for AAV Gene...
Amicus Therapeutics announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.